ronbanged2 schreef:
[quote=king1]
Ron inderdaad dramatische week Crucell 4% gestegen en dit is slechts t begin er komt nog veel meer mooi nieuws aan ! Schrijf iets zinvols of zwijg !!!!
[/quote]
Brus-o-philes, who worship at the alter of hair gel, primping, narcissism, ego-stroking and boat parties. You know, you know, who you are. Bow and scrape at the feet of the master of the "biggest deal ever", the vanishing POC, and the shrinking stock price. You get flushed each time you hear "you know" and "soon, very soon", and feel a tingling each time you are told The Ego is "building shareholder value".
He dilutes the shares every chance he gets instead of growing organically. He can't move a single product candidate or project along...they all languish and die...or go into perpetual phase I limbo. This is particularly worrisome because it would be so great for the facility in Korea to get up and running early, what with the troubles at Shantha. But the easy work is now done, and now is the time for planning and execution. One can only hope that Brus delegates it to someone competent.
Where is Epaxal Jr in the US? One of Brus's many no-brainers. My guess is that is was a bluff to try and get another company to partner...but they all know Brus is full of hot air, and Crucell will simply abandon this no-brainer when he finds out he may have to give up a "spa day" with Oya to get it done.
Where are the benefits from the J+J deal? So far we have seen nothing. Where is Wyeth? Medimmune?
STAR? Ebola will fade and the contract go to another company....still in phase I after 5 years. Rabies...Brus' chance to show he can actually shephard a project...given fat track staus...already stalling out...along with the milestones and income it would bring...all because of incompetence.
Dump Brus
Give management no more shares to squander
Limit managment options to the J+J price of 21 euro.
Price would then soon double